Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Sarcoma Foundation of America, Cure Kids Cancer, NICHD/NIH Specialized Centers in Research in Pediatric Developmental Pharmacology
Grant: P50HD090215
Sarcoma Foundation of America, Cure Kids Cancer, NICHD/NIH Specialized Centers in Research in Pediatric Developmental Pharmacology
Grant: P30CA082709
Pediatric and AYA Sarcoma modeling Indiana University Precision Health Initiative (Pollok)
Grant: Not Applicable
National Institutes of Health
Grant: 5P50HD090215-05
Indiana University Center for Pediatric Pharmacology and Precision Medicine
National Institutes of Health
Grant: 3P30CA082709-16S3
Indiana University Melvin and Bren Simon Cancer Center Support Grant
FWCI
1.64
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals